Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Menlo Therapeutics Inc (MNLO)

Menlo Therapeutics Inc (MNLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team Business Wire - Tue Jan 26, 2021

Frazier Healthcare Partners announced the planned addition of Albert Cha, M.D., Ph.D. as Managing Partner on the Life Sciences team. He has over 20 years of experience investing in public and private biopharmaceutical...

ASND : 139.65 (-0.01%)
KALV : 12.49 (-3.78%)
ACRS : 1.1700 (-1.68%)
BHVN : 38.11 (-3.05%)
MNLO : 1.3500 (-2.17%)
SRRA : 54.99 (+0.04%)
BIOD : 0.65 (+6.56%)
VYNE Therapeutics (formerly Menlo Therapeutics) to Present at the Cantor Fitzgerald and H.C. Wainwright Investment Conferences in September Globe NewsWire - Wed Sep 9, 2020

BRIDGEWATER, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present...

MNLO : 1.3500 (-2.17%)
VYNE : 1.7300 (+1.17%)
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics Globe NewsWire - Tue Sep 8, 2020

Will commence trading under new Nasdaq Ticker “VYNE”, September 8, 2020

MNLO : 1.3500 (-2.17%)
VYNE : 1.7300 (+1.17%)
Menlo Therapeutics Announces Corporate Name Change to VYNE Therapeutics Globe NewsWire - Wed Sep 2, 2020

Company will commence trading under new ticker “VYNE” on September 8, 2020

MNLO : 1.3500 (-2.17%)

Barchart Exclusives

3 Safe High-Yield Dividend Stocks to Pounce on Now Barchart - Wed Aug 14, 6:30PM CDT
In today's volatile market, dividend stocks remain one of the safest choices. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot